HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU

HARCP Archives

Browse by volume Browse by article Published Ahead
of Print
 

 

 

If you want to download the journal, please login or register as reader.

2011 Issues

Cover

Vol. 13 • No. 1 • March 2011

In this issue:

  • Tobacco smoking prevalence in a large sample of heroin users accessing rehabilitation
    Pajusco B., Boschini A., Chiamulera C., Begnini M., Smacchia C., Lugoboni F.
  • Housing and employment situation, body mass index and dietary habits of heroin addicts in methadone maintenance treatment
    Alves D., Costa A. F., Custódio D., Natário L., Ferro-Lebres V., Andrade F.
  • Effect of valproate on benzodiazepine withdrawal severity in opioid-dependent subjects: a pilot study
    Vorma H., Katila H.
  • Opioid addiction complicated by alcoholism (in young men)
    Blagov L. N., Kurgak D. I.
  • Dual Diagnosis (Comorbidity): A growing diagnostic and treatment issue in the psychiatric and substance use programmes in the Republic of Macedonia
    Tulevski I. G.
  • Does cannabis have therapeutic benefits for withdrawing opioid addicts?
    Peloquin M., Peters L. R., Mclarnon M. E., Barrett S. P.
  • Is it time for new studies on the level of insight in heroin addicts to promote compliance with methadone treatment?
    Rovai L., Maremmani A. G. I.

 

Cover

Vol. 13 • No. 2 • June 2011

In this issue:

  • Basics on Addiction: a training package for medical practitioners or psychiatrists who treat opioid dependence
    Maremmani I., Pacini M., Pani P. P., On Behalf of the 'Basics on Addiction Group'

 

Cover

Vol. 13 • No. 3 • September 2011

In this issue:

  • Therapeutic management and comorbidities in opiate-dependent patients undergoing a replacement therapy programme in Spain: the PROTEUS study
    Roncero C., Fuste G., Barral C., Rodríguez-Cintas L., Martínez-Luna N., Eiroa-Orosa F. J., Casas M., On Behalf of the Proteus Study Investigators
  • Life events (loss and traumatic) and emotional responses to them in heroin-dependent patients before and after the dependence age of onset
    Rugani F., Maremmani A. G. I., Rovai L., Mautone S., Perugi P., Pani P. P., Dell'osso L., Maremmani I.
  • A comparison of the drug use patterns, measures of needs and quality of life of methadone maintained patients using and not using cocaine
    Ducray K., Byrne P., Burke C., Smyth B. P.
  • Sociodemographic and clinical differences among deceased and surviving cohort members of opioid maintenance therapy
    Lovrečič B., Šemerl J. S., Tavčar R., Maremmani I.

 

Cover

Vol. 13 • No. 4 • December 2011

In this issue:

  • Self-reported differences in side-effects for 110 heroin addicts during opioid addiction and during methadone treatment
    Grönbladh L., Öhlund L. S.
  • Latent suicidality in heroin addicts
    Budiša D., Gavrilov-Jerković V., Dickov A., Vučković N., Mitrović D., Svilokos S.
  • Patients who use alcohol during MMT receive lower doses of methadone, show fewer positive urine analyses for opioids, and suffer from PTSD more frequently
    Softić J., Awad H.
  • Further evidence of no relationship between anxiety-depressive mental status and dual diagnosis in heroin addicts entering treatment
    Lovrecic M., Lovrecic B., Rovai L., Rugani F., Maremmani A. G. I., Maremmani I.
  • Requiring stabilized heroin addicts to stop successfull agonist opioid treatment before liver transplantation can shift patients over a cross-acting (alcohol) substance abuse
    Piz L., Maremmani A. G. I., Rugani F., Pacini M., Rovai L., Dell'osso L., Maremmani I.
  • Suboxone® switch data: A regional experience
    Leonardi C.
  • What concept of ‘spectrum' is useful in addiction medicine?
    Rovai L., Rugani F., Bacciardi S., Maremmani A. G. I.

 

 

AU-CNS Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 – 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 – Codice Fiscale 94002580465
Tel/Phone: 0584 - 790073 - Fax: 0584-72081 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page